Neuropathix, Inc.
NPTX · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $22 | $121 | $307 |
| Short-Term Investments | $0 | $0 | $0 | $2,580 |
| Receivables | $0 | $0 | $0 | $116 |
| Inventory | -$122,312,878 | -$160,999,839 | -$8,999,991 | -$2,595,974,000 |
| Other Curr. Assets | $122,313,000 | $161,000,000 | $9,000,000 | $2,595,974,000 |
| Total Curr. Assets | $138 | $183 | $131 | $3,003 |
| Property Plant & Equip (Net) | $69 | $59 | $75 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $17 | $17 | $17 | $17 |
| Total NC Assets | $86 | $76 | $93 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $225 | $260 | $223 | $3,023 |
| Liabilities | – | – | – | – |
| Payables | $486 | $539 | $389 | $284 |
| Short-Term Debt | $1,404 | $1,199 | $670 | $16 |
| Tax Payable | $241 | $0 | $243 | $246 |
| Deferred Revenue | $113 | $617 | $0 | $0 |
| Other Curr. Liab. | $739 | $191 | $25 | $0 |
| Total Curr. Liab. | $2,983 | $2,546 | $1,327 | $546 |
| LT Debt | $505 | $466 | $407 | $1,146 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $723 | $443 | $183 | $0 |
| Total NC Liab. | $1,228 | $909 | $590 | $1,146 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,211 | $3,454 | $1,917 | $1,692 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9 | $8 | $7 | $7 |
| Retained Earnings | -$16,591 | -$13,033 | -$8,496 | -$5,052 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $12,595 | $9,831 | $6,795 | $6,382 |
| Total Equity | -$3,987 | -$3,195 | -$1,694 | $1,337 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | -$6 |
| Total Liab. & Tot. Equity | $225 | $260 | $223 | $3,023 |
| Net Debt | $1,893 | $1,642 | $955 | $855 |